NMDA receptor-deficient mice display sexual dimorphism in the onset and severity of behavioural abnormalities

Genes, Brain and Behavior

Volumn 13, Issue 8, 2014, Pages 850-862

  Milenkovic, M ^a   Mielnik, C A ^a   Ramsey, A J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cognition; Executive function; GluN1; Grin1; Locomotor activity; Mouse; Neurodevelopmental disorder; Schizophrenia; Social behaviour; Stereotypy; Working memory

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; NR1 NMDA RECEPTOR;

ADOLESCENT; ADULT; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DISEASE SEVERITY; EXECUTIVE FUNCTION; FEMALE; JUVENILE ANIMAL; LOCOMOTION; MALE; MEMORY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROBLEM SOLVING; PROTEIN FUNCTION; SEX DIFFERENCE; SOCIAL BEHAVIOR; STEREOTYPY; WORKING MEMORY; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; SEXUAL DEVELOPMENT; SHORT TERM MEMORY;

MUS;

AGE FACTORS; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; EXECUTIVE FUNCTION; FEMALE; MALE; MEMORY, SHORT-TERM; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; RECEPTORS, N-METHYL-D-ASPARTATE; SEX CHARACTERISTICS; SOCIAL BEHAVIOR; STEREOTYPED BEHAVIOR;

EID: 84911453943     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/gbb.12183     Document Type: Article

References (52)

1. Banbury Conference (1997) Mutant mice and neuroscience: recommendations concerning genetic background. Banbury Conference on genetic background in mice. Neuron 19, 755-759.
2. Bejerano, G., Pheasant, M., Makunin, I., Stephen, S., Kent, W.J., Mattick, J.S. & Haussler, D. (2004) Ultraconserved elements in the human genome. Science 304, 1321-1325.
3. Ben Abdallah, N.M., Fuss, J., Trusel, M., Galsworthy, M.J., Bobsin, K., Colacicco, G., Deacon, R.M., Riva, M.A., Kellendonk, C., Sprengel, R., Lipp, H.P. & Gass, P. (2011) The puzzle box as a simple and efficient behavioral test for exploring impairments of general cognition and executive functions in mouse models of schizophrenia. Exp Neurol 227, 42-52.
4. Bergen, S.E., O'Dushlaine, C.T., Lee, P.H., Fanous, A.H., Ruderfer, D.M., Ripke, S., International Schizophrenia Consortium, S.S.C., Sullivan, P.F., Smoller, J.W., Purcell, S.M. & Corvin, A. (2014) Genetic modifiers and subtypes in schizophrenia: investigations of age at onset, severity, sex and family history. Schizophr Res 154, 48-53.
5. Bickel, S., Lipp, H.P. & Umbricht, D. (2007) Impaired attentional modulation of auditory evoked potentials in N-methyl-D-aspartate NR1 hypomorphic mice. Genes Brain Behav 6, 558-568.
6. Bickel, S., Lipp, H.P. & Umbricht, D. (2008) Early auditory sensory processing deficits in mouse mutants with reduced NMDA receptor function. Neuropsychopharmacology 33, 1680-1689.
7. Bitanihirwe, B.K., Peleg-Raibstein, D., Mouttet, F., Feldon, J. & Meyer, U. (2010) Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology 35, 2462-2478.
8. van den Buuse, M., Halley, P., Hill, R., Labots, M. & Martin, S. (2012) Altered N-methyl-D-aspartate receptor function in reelin heterozygous mice: male-female differences and comparison with dopaminergic activity. Prog Neuropsychopharmacol Biol Psychiatry 37, 237-246.
9. Crespi, B. & Badcock, C. (2008) Psychosis and autism as diametrical disorders of the social brain. Behav Brain Sci 31, 241-261 discussion 261-320.
10. Dimassi, S., Andrieux, J., Labalme, A., Lesca, G., Cordier, M.P., Boute, O., Neut, D., Edery, P., Sanlaville, D. & Schluth-Bolard, C. (2013) Interstitial 12p13.1 deletion involving GRIN2B in three patients with intellectual disability. Am J Med Genet A 161, 2564-2569.
11. Duncan, G.E., Moy, S.S., Perez, A., Eddy, D.M., Zinzow, W.M., Lieberman, J.A., Snouwaert, J.N. & Koller, B.H. (2004) Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behav Brain Res 153, 507-519.
12. Dzirasa, K., Ramsey, A.J., Takahashi, D.Y., Stapleton, J., Potes, J.M., Williams, J.K., Gainetdinov, R.R., Sameshima, K., Caron, M.G. & Nicolelis, M.A. (2009) Hyperdopaminergia and NMDA receptor hypofunction disrupt neural phase signaling. J Neurosci 29, 8215-8224.
13. Ehninger, D., Li, W., Fox, K., Stryker, M.P. & Silva, A.J. (2008) Reversing neurodevelopmental disorders in adults. Neuron 60, 950-960.
14. Esterberg, M.L., Trotman, H.D., Holtzman, C., Compton, M.T. & Walker, E.F. (2010) The impact of a family history of psychosis on age-at-onset and positive and negative symptoms of schizophrenia: a meta-analysis. Schizophr Res 120, 121-130.
15. Ferris, M.J., Milenkovic, M., Liu, S., Mielnik, C.A., Beerepoot, P., John, C.E., Espana, R.A., Sotnikova, T.D., Gainetdinov, R.R., Borgland, S.L., Jones, S.R. & Ramsey, A.J. (2014) Sustained N-methyl-d-aspartate receptor hypofunction remodels the dopamine system and impairs phasic signaling. Eur J Neurosci 40, 2255-2263.
16. Fradley, R.L., O'Meara, G.F., Newman, R.J., Andrieux, A., Job, D. & Reynolds, D.S. (2005) STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav Brain Res 163, 257-264.
17. Fromer, M., Pocklington, A.J., Kavanagh, D.H. et al. (2014) De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179-184.
18. Gainetdinov, R.R., Jones, S.R. & Caron, M.G. (1999) Functional hyperdopaminergia in dopamine transporter knock-out mice. Biol Psychiatry 46, 303-311.
19. Gainetdinov, R.R., Mohn, A.R., Bohn, L.M. & Caron, M.G. (2001a) Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proc Natl Acad Sci U S A 98, 11047-11054.
20. Gainetdinov, R.R., Mohn, A.R. & Caron, M.G. (2001b) Genetic animal models: focus on schizophrenia. Trends Neurosci 24, 527-533.
21. Galsworthy, M.J., Paya-Cano, J.L., Liu, L., Monleon, S., Gregoryan, G., Fernandes, C., Schalkwyk, L.C. & Plomin, R. (2005) Assessing reliability, heritability and general cognitive ability in a battery of cognitive tasks for laboratory mice. Behav Genet 35, 675-692.
22. Gandal, M.J., Anderson, R.L., Billingslea, E.N., Carlson, G.C., Roberts, T.P. & Siegel, S.J. (2012) Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia? Genes Brain Behav 11, 740-750.
23. Gass, P., Wolfer, D.P., Balschun, D., Rudolph, D., Frey, U., Lipp, H.P. & Schutz, G. (1998) Deficits in memory tasks of mice with CREB mutations depend on gene dosage. Learn Mem 5, 274-288.
24. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M. & Caron, M.G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
25. Grant, S.G. (2012) Synaptopathies: diseases of the synaptome. Curr Opin Neurobiol 22, 522-529.
26. Graves, L., Dalvi, A., Lucki, I., Blendy, J.A. & Abel, T. (2002) Behavioral analysis of CREB alphadelta mutation on a B6/129F1 hybrid background. Hippocampus 12, 18-26.
27. Halene, T.B., Ehrlichman, R.S., Liang, Y., Christian, E.P., Jonak, G.J., Gur, T.L., Blendy, J.A., Dow, H.C., Brodkin, E.S., Schneider, F., Gur, R.C. & Siegel, S.J. (2009) Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia. Genes Brain Behav 8, 661-675.
28. Holley, S.M., Wang, E.A., Cepeda, C., Jentsch, J.D., Ross, C.A., Pletnikov, M.V. & Levine, M.S. (2013) Frontal cortical synaptic communication is abnormal in Disc1 genetic mouse models of schizophrenia. Schizophr Res 146, 264-272.
29. Keshavan, M.S. (1999) Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiatr Res 33, 513-521.
30. Leung, A. & Chue, P. (2000) Sex differences in schizophrenia, a review of the literature. Acta psychiatrica Scandinavica. Supplementum 401, 3-38.
31. Lisman, J.E., Coyle, J.T., Green, R.W., Javitt, D.C., Benes, F.M., Heckers, S. & Grace, A.A. (2008) Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 31, 234-242.
32. MacLaren, E.J., Charlesworth, P., Coba, M.P. & Grant, S.G. (2011) Knockdown of mental disorder susceptibility genes disrupts neuronal network physiology in vitro. Mol Cell Neurosci 47, 93-99.
33. Mandillo, S., Tucci, V., Holter, S.M. et al. (2008) Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory study. Physiol Genomics 34, 243-255.
34. Mielnik, C.A., Horsfall, W. & Ramsey, A.J. (2014) Diazepam improves aspects of social behaviour and neuron activation in NMDA receptor-deficient mice. Genes Brain Behav 13, 592-602.
35. Moghaddam, B. & Javitt, D. (2012) From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 37, 4-15.
36. Mohn, A.R., Gainetdinov, R.R., Caron, M.G. & Koller, B.H. (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98, 427-436.
37. Morice, E., Farley, S., Poirier, R., Dallerac, G., Chagneau, C., Pannetier, S., Hanauer, A., Davis, S., Vaillend, C. & Laroche, S. (2013) Defective synaptic transmission and structure in the dentate gyrus and selective fear memory impairment in the Rsk2 mutant mouse model of Coffin-Lowry syndrome. Neurobiol Dis 58, 156-168.
38. Moy, S.S., Nadler, J.J., Perez, A., Barbaro, R.P., Johns, J.M., Magnuson, T.R., Piven, J. & Crawley, J.N. (2004) Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 3, 287-302.
39. Moy, S.S., Perez, A., Koller, B.H. & Duncan, G.E. (2006) Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function. Brain Res 1089, 186-194.
40. Moy, S.S., Nikolova, V.D., Riddick, N.V., Baker, L.K. & Koller, B.H. (2012) Preweaning sensorimotor deficits and adolescent hypersociability in Grin1 knockdown mice. Dev Neurosci 34, 159-173.
41. Nadler, J.J., Moy, S.S., Dold, G., Trang, D., Simmons, N., Perez, A., Young, N.B., Barbaro, R.P., Piven, J., Magnuson, T.R. & Crawley, J.N. (2004) Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav 3, 303-314.
42. Olney, J.W., Wozniak, D.F., Farber, N.B., Jevtovic-Todorovic, V., Bittigau, P. & Ikonomidou, C. (2002) The enigma of fetal alcohol neurotoxicity. Ann Med 34, 109-119.
43. Penzes, P., Cahill, M.E., Jones, K.A., VanLeeuwen, J.E. & Woolfrey, K.M. (2011) Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci 14, 285-293.
44. Ramsey, A.J., Laakso, A., Cyr, M., Sotnikova, T.D., Salahpour, A., Medvedev, I.O., Dykstra, L.A., Gainetdinov, R.R. & Caron, M.G. (2008) Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine. Neuropsychopharmacology 33, 2701-2714.
45. Ramsey, A.J., Milenkovic, M., Oliveira, A.F., Escobedo-Lozoya, Y., Seshadri, S., Salahpour, A., Sawa, A., Yasuda, R. & Caron, M.G. (2011) Impaired NMDA receptor transmission alters striatal synapses and DISC1 protein in an age-dependent manner. Proc Natl Acad Sci U S A 108, 5795-5800.
46. Rapoport, J.L., Giedd, J.N. & Gogtay, N. (2012) Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry 17, 1228-1238.
47. Sargin, D., Mercaldo, V., Yiu, A.P., Higgs, G., Han, J.-H.H., Frankland, P.W. & Josselyn, S.A. (2012) CREB regulates spine density of lateral amygdala neurons: implications for memory allocation. Front Behav Neurosci 7, 209.
48. Scott, O., Richer, L., Forbes, K., Sonnenberg, L., Currie, A., Eliyashevska, M. & Goez, H.R. (2014) Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis: an unusual cause of autistic regression in a toddler. J Child Neurol 29, 691-694.
49. Stefansson, H., Meyer-Lindenberg, A., Steinberg, S. et al. (2014) CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature 505, 361-366.
50. Tamminga, C.A. & Holcomb, H.H. (2005) Phenotype of schizophrenia: a review and formulation. Mol Psychiatry 10, 27-39.
51. Uzunova, G., Hollander, E. & Shepherd, J. (2014) The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile X syndrome. Curr Neuropharmacol 12, 71-98.
52. Waites, C.L., Craig, A.M. & Garner, C.C. (2005) Mechanisms of vertebrate synaptogenesis. Annu Rev Neurosci 28, 251-274.